Diagnostic and Prognostic Role of CD93 in Cardiovascular Disease: A Systematic Review.
Federica PianiGiovanni TossettaGabriel Cara-FuentesDavide AgnolettiDaniela MarzioniClaudio BorghiPublished in: Biomolecules (2023)
A total of 182 references were identified, and 15 studies investigating the associations between CD93 protein levels or CD93 genetic polymorphisms and the development or prevalence of CV risk factors (i.e., hypertension, dyslipidemia, and obesity) and CVD (i.e., heart failure, coronary artery disease, and ischemic stroke) were included. Although promising, the quality and dimension of the analyzed studies do not allow for a definitive answer to the question of whether CD93 may hold diagnostic and prognostic value in CVD.
Keyphrases
- risk factors
- heart failure
- cardiovascular disease
- coronary artery disease
- type diabetes
- blood pressure
- metabolic syndrome
- atrial fibrillation
- insulin resistance
- squamous cell carcinoma
- weight loss
- left ventricular
- cardiovascular events
- radiation therapy
- acute coronary syndrome
- case control
- quality improvement
- coronary artery bypass grafting
- physical activity
- binding protein
- high fat diet induced